產(chǎn)品展示
優(yōu)質(zhì)供應(yīng)
詳細(xì)內(nèi)容
艾美捷LKT Labs 胰高血糖素樣肽II，大鼠 #G4485參數(shù)說明：
Cas No.：89750-15-2
純度：≥95%
公式：C165H254N44O55S
配方重量：3766.2
同義詞：GLP-2
儲(chǔ)存溫度：-20°C
LKT Labs 胰高血糖素樣肽II，大鼠文獻(xiàn)引用：
Sasaki-Hamada S, Ito K, Oka JI. Neuronal Fos-like immunoreactivity associated with dexamethasone-induced hypertension in rats ａnd effects of glucagon-like peptide-2. Life Sci. 2013 Oct 24. pii: S0024-3205(13)00618-8. [Epub ahead of print]. PMID: 24513200.
Hansen LB. GLP-2 ａnd mesenteric blood flow. Dan Med J. 2013 May;60(5):B4634. PMID: 23673268.
Rasmussen AR, Viby NE, Hare KJ, et al. The intestinotrophic peptide, GLP-2, counteracts the gastrointestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor, erlotinib, ａnd cisplatin. Dig Dis Sci. 2010 Oct;55(10):2785-96. PMID: 20112065.
Wang Y, Guan X. GLP-2 potentiates L-type Ca2+ channel activity associated with stimulated glucose uptake in hippocampal neurons. Am J Physiol Endocrinol Metab. 2010 Feb;298(2):E156-66. PMID: 19920220.
Iwai T, Hayashi Y, Narita S, et al. Antidepressant-like effects of glucagon-like peptide-2 in mice occur via monoamine pathways. Behav Brain Res. 2009 Dec 1;204(1):235-40. PMID: 19539656.
Mojsov S, Kopczynski MG, Habener JF. Both amidated ａnd nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine ａnd the pancreas. J Biol Chem. 1990 May 15;265(14):8001-8. PMID: 1692320.
LKT Laboratories（LKT Labs）注于防癌抗癌特殊化學(xué)品研究和開發(fā)域。主要包括：癌癥藥物、藥物發(fā)現(xiàn)試劑盒、天然產(chǎn)物、廣泛的生命科學(xué)研究試劑、定制合成等。同時(shí)注研究用小分子的合成，純化和分離。主要應(yīng)用于癌癥和神經(jīng)科學(xué)等，包括蛋白激酶抑制劑、離子通道調(diào)節(jié)劑和激活劑等。艾美捷科技是LKT Labs的中國代理商，為科研工作者提供優(yōu)質(zhì)的產(chǎn)品與服務(wù)。
